Answers are grounded in this paper and cite their sources.
Polymethyl methacrylate remains the only US Food and Drug Administration-approved method of total elbow arthroplasty fixation and exhibits high aseptic loosening rates that result in challenging revision surgeries and potential morbidity secondary to bone-cement implantation syndrome. In this policy paper, the authors aim to explore the historical background of polymethyl methacrylate and the complications that arise in association with its use. We will review arthroplasty trends in the elbow and lower extremities and the challenges with the US Food and Drug Administration-approval process. Polymethyl methacrylate remains the only US Food and Drug Administration-approved method of total elbow arthroplasty fixation and exhibits high aseptic loosening rates that result in challenging revision surgeries and potential morbidity secondary to bone-cement implantation syndrome. In this policy paper, the authors aim to explore the historical background of polymethyl methacrylate and the complications that arise in association with its use. We will review arthroplasty trends in the elbow and lower extremities and the challenges with the US Food and Drug Administration-approval process. Since 1976, the only approved method for total elbow arthroplasty fixation is with the use of polymethyl methacrylate (PMMA). This material fills the void between the implant and bone and quickly dries in an exothermic reaction. How did this material become the only approved method for upper-extremity implantation? To answer this question, we must retrace our steps back to 1969 when President Richard Nixon tasked the director of the National Heart and Lung Institute, Theodore Cooper, MD, to study the regulation of medical technology. Dr Cooper’s initiative recommended that the Food and Drug Administration (FDA) expand its supervision of medical devices and suggested a practical method to regulate emerging technologies.1FDA medical device regulation.in: Mantus D. Pisano D.J. FDA medical device regulation. In: FDA Regulatory Affairs. Third Edition. CRC Press, 2014: 137-180Google Scholar This group proposed that technology of the early 1970s be considered the state of the art. Any novel implant would be stratified by the FDA based on a perceived level of risk. Three classes were to be created. Class I devices were considered unlikely to cause injury to the patient. Class II devices were designated as posing a higher risk than class I and, therefore, required a higher level of oversight to ensure that they did not cause harm. Class II devices would also establish their safety and effectiveness by demonstrating that they were equivalent to another predicate device that was currently available on the market. Additional metrics included device performance testing, postmarket surveillance, patient registries, and labeling requirements. This procedure became known as the 510(k) pathway, named after its specific section within the 1976 Food, Drug, and Cosmetic Act. Class III devices would pose the greatest risk to the patient and would generally require a multi-million dollar premarket approval (PMA) process to establish their safety and effectiveness, which would often include clinical trials. Since its inception, the PMA process has required such substantial time and resources that only 70 orthopedic devices were cleared via the PMA pathway between 1982 and 2014.2Schultz H.W. Federal Food, Drug, and Cosmetic Act.in: Food Law Handbook. Springer Netherlands, 1981: 530-546Crossref Google Scholar The vast majority were spine implants or devices related to hip and knee arthroplasties. There were only two upper extremity implants, one each for thumb carpometacarpal arthroplasty and metacarpophalangeal implant arthroplasty.3Samuel A.M. Rathi V.K. Grauer J.N. Ross J.S. How do orthopaedic devices change after their initial FDA premarket approval?.Clin Orthop Relat Res. 2016; 474: 1053-1068Crossref PubMed Scopus (24) Google Scholar Since 1976, thousands of 510(k) applications have been received, which also have a much lower $12,745 application fee when compared with the $374,858.4 PMA fee. With this approach, change occurs in iterations, given that once a new technology is introduced via the 510(k) pathway, it then becomes the predicate for the next “substantially equivalent” design. Over the years, this process has been successful in mitigating risk with few exceptions, such as the metal-on-metal hip arthroplasty.4Shah A. Olson M.M. Maurice J.M. Review of approvals and recalls of US specific medical devices in general and plastic surgery.Surg Pract Sci. 2023; 12100158Google Scholar,5Ardaugh B.M. Graves S.E. Redberg R.F. The 510(k) ancestry of a metal-on-metal hip implant.N Engl J Med. 2013; 368: 97-100Crossref PubMed Scopus (83) Google Scholar In addition to categorizing risk, Dr Cooper's recommendations also established the state of the art. The technology of 1976 was grandfathered in and, because the PMA pathway is so expensive, the orthopedic industry has been reluctant to introduce novel devices or fixation methods unless the market and return on investment are large. Although PMMA is the only current FDA–approved fixation strategy for total elbow arthroplasty, it has substantial limitations and poses morbidity risks to patients. PMMA is a synthetic polymer derived from methyl methacrylate. It is a transparent thermoplastic and is frequently referred to by one of its trade names, Plexiglas (Röhm GmbH). It was first produced in 1928, and some of the original applications were in World War II for submarine periscopes, airplane windows, turrets, and canopies. Its first application in medicine was in the 1940s to close gaps within the skull. Since 1950, bone cement has been used for anchoring prostheses and was championed in 1958 by British surgeon Sir John Charnley. Dr Charnley used cement to secure a cup into the acetabulum and a metal stem with the ball into the femur. The cement filled the free space between the implant components and bone. Barium sulfate was added to make the material radiopaque. The technique of “cementing” became the standard for fixation of total hips, knees, shoulders, wrists, and elbows. When Cooper began regulating medical devices in 1969, cement fixation of implants was so popular that it was considered “state of the art.” Cement offered a quick and, in the near term, reliable bone-to-implant fixation.6Kuehn K.D. Ege W. Gopp U. Acrylic bone cements: composition and properties.Orthop Clin North Am. 2005; 36: 17-28Abstract Full Text Full Text PDF PubMed Scopus (167) Google Scholar Unfortunately, PMMA also generates substantial heat as it dries, which is often absorbed by the implant and dissipated via blood flow through bone. Intraoperative studies have shown temperatures as high as 65°C within the cement and 56°C at the bone-cement interface. These temperatures exceed the thermal-necrosis threshold of bone (53°C).7Berman A.T. Reid J.S. Yanicko D.R. Sih G.C. Zimmerman M.R. Thermally induced bone necrosis in rabbits. Relation to implant failure in humans.Clin Orthop Relat Res. 1984; 186: 284-292Crossref PubMed Google Scholar Bones that are stripped of soft tissue attachments and where the cement mantle is large are vulnerable and may be damaged by this exothermic reaction. Revision efforts that use ultrasonic cement removal devices will also cause thermal damage above known thresholds for thermal necrosis.8Goldberg S.H. Cohen M.S. Young M. Bradnock B. Thermal tissue damage caused by ultrasonic cement removal from the humerus.J Bone Joint Surg Am. 2005; 87: 583-591Crossref PubMed Scopus (36) Google Scholar,9Goldberg S.H. Studders E.M. Cohen M.S. Ultrasonic cement removal in revision arthroplasty.Orthopedics. 2007; 30: 632-635Crossref PubMed Scopus (19) Google Scholar PMMA is designed to fill the space between the implant and bone but, in doing so, makes a cemented implant smaller than an implant otherwise would be if it did not need to share the intramedullary canal with the PMMA. By acting as a grout between the bone and the implant, it does not promote osseointegration, which is defined as “the formation of a direct interface between an implant and bone, without intervening soft tissue.”10Miller-Keane encyclopedia and dictionary of medicine, nursing, and allied health.Gastroenterol Nurs. 1993; 15: 258Crossref Google Scholar Without osseointegration, the bond between the PMMA and bone can weaken, leading to component instability and implant failure. An inadequate cement mantle, mechanical stress, and biological responses may all contribute to this process. One study showed 50% aseptic loosening rates at a long-term follow-up in young patients.11Callaghan J.J. Forest E.E. Olejniczak J.P. Goetz D.D. Johnston R.C. Charnley total hip arthroplasty in patients less than fifty years old. A twenty to twenty-five-year follow-up note.J Bone Joint Surg Am. 1998; 80: 704-714Crossref PubMed Google Scholar Cementless implants employ roughened surfaces to facilitate the growth of bone into the implant. These features provide a mechanical interlock to limit micromotion before osseointegration. In the lower extremities, newly designed total knee implants are demonstrating increased durability and longevity, which may be valuable for younger and more active patient populations requiring total knee arthroplasty.12Prasad A.K. Tan J.H.S. Bedair H.S. Dawson-Bowling S. Hanna S.A. Cemented vs. cementless fixation in primary total knee arthroplasty: a systematic review and meta-analysis.EFORT Open Rev. 2020; 5: 793-798Crossref Scopus (27) Google Scholar Currently, it is unclear whether cemented or uncemented implants are superior regarding mechanical stability.13Albrektsson B.E. Ryd L. Carlsson L.V. et al.The effect of a stem on the tibial component of knee arthroplasty. A roentgen stereophotogrammetric study of uncemented tibial components in the Freeman-Samuelson knee arthroplasty.J Bone Joint Surg Br. 1990; 72: 252-258Crossref PubMed Google Scholar The financial cost of PMMA is not substantial even when one adds antibiotics and methylene blue dye that allows for easier identification during revision surgery. It does become more expensive when one includes the cost of an ultrasonic cement removal system and then the additional cement required with each revision effort. The real toll for the patient and surgeon lies in the difficulty in removing cement and the possibility that not all of it may be eradicated, which is unacceptable in the face of an infection. Eliminating cement is time-consuming and technically demanding because PMMA is often harder than the native bone and must be removed with chisels and curettes. Frequently, an osteotomy is performed to create bone windows that allow access to the cement. Bone fracture, cement extravasation, and injury to adjacent nerves may occur.14Throckmorton T.W. Zarkadas P.C. Sanchez-Sotelo J. Morrey B.F. Radial nerve palsy after humeral revision in total elbow arthroplasty.J Shoulder Elbow Surg. 2011; 20: 199-205Abstract Full Text Full Text PDF PubMed Scopus (16) Google Scholar,15Waitzenegger T. Mansat P. Guillon P. et al.Radial nerve palsy in surgical revision of total elbow arthroplasties: A study of 4 cases and anatomical study, possible aetiologies and prevention.Orthop Traumatol Surg Res. 2015; 101: 903-907Abstract Full Text Full Text PDF Google Scholar Infections after total elbow arthroplasty are devastating problems. A dorsal incision through the elbow’s thin soft tissue envelope and the exothermic cement curing may contribute to their incidence. To eradicate an infection, all the cement must be removed to avoid biofilm formation on the PMMA. Persistent biofilms can lead to chronic or recurrent infections, requiring additional interventions or revision surgeries and hampering the effectiveness of antibiotic treatment. To avoid infection, the use of PMMA cement with antibiotic additives (eg, gentamicin and tobramycin) is often used. Although this can help reduce the risk of infection, it may also lead to antibiotic resistance, potentially complicating future treatment options. Another troubling finding is that bacteria can survive on tobramycin-impregnated cement.16Stoodley P. Nistico L. Johnson S. et al.Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty. A case report.J Bone Joint Surg Am. 2008; 90: 1751-1758Crossref PubMed Scopus (0) Google Scholar Bone-cement implantation syndrome (BCIS) is a unique problem associated with cement fixation of an implant. It occurs primarily in association with cemented total hip arthroplasty and is characterized by hypoxia and hypotension occurring around the time of cementation.17Mudgalkar N. Ramesh K.V. Bone cement implantation syndrome: a rare catastrophe.Anesth Essays Res. 2011; 5: 240-242Crossref Google Scholar It is poorly understood and yet remains an important cause of intraoperative mortality and morbidity. A single institution, retrospective review of all patients undergoing hip arthroplasty over 28 years, demonstrated that all 23 patients who died during surgery sustained irreversible cardiorespiratory disturbances that were initiated during cementing. No deaths were among the 15,411 uncemented hip arthroplasties.18Parvizi J. Holiday A.D. Ereth M.H. Lewallen D.G. The Frank Stinchfield Award. Sudden death during primary hip arthroplasty.Clin Orthop Relat Res. 1999; : 39-48Crossref Scopus (210) Google Scholar In our institutional experience, one senior author (R.A.K.) had a patient develop BCIS after a cemented distal humerus hemiarthroplasty, which required prolonged extracorporeal membrane oxygenation. Although rare, the morbidity of BCIS can be devastating. Although cementation exhibits drawbacks, the luxury of comparing implant fixation options, such as in knee or hip arthroplasty, does not exist in the realm of total elbow replacements. Current FDA regulations are needed to safeguard patients and represent a challenge to the development of novel fixation methods for total elbow arthroplasty. One fixation consideration may be to promote osseointegration similar to what occurs in hip arthroplasty. This could be performed with an intramedullary screw incorporated into the ulnar and humeral components. As the screw advances, it would pull the implant into a cavity created by drilling and broaching efforts. A snug fit would serve to increase implant stability and allow for bone integration.19Shetty S. Nelson B. Knopp B. Schneppendahl J. Kaufmann R.A. Strength of humeral and ulnar intramedullary screw fixation.J Hand Surg Am. 2022; 47: 1014.e1-1014.e8Abstract Full Text Full Text PDF PubMed Scopus (5) Google Scholar,20Brånemark R. Berlin O. Hagberg K. Bergh P. Gunterberg B. Rydevik B. A novel osseointegrated percutaneous prosthetic system for the treatment of patients with transfemoral amputation: a prospective study of 51 patients.Bone Joint J. 2014; 96-B: 106-113Crossref PubMed Scopus (0) Google Scholar We are approaching a half-century where it has been mandatory to use bone cement for elbow arthroplasty. Given its drawbacks, alternative methods such as press fit fixation or intramedullary screw fixation may warrant consideration. In the lower extremity, cemented and uncemented implants are being evaluated regarding implant longevity with a trend toward uncemented implants.21Schwabe M.T. Hannon C.P. The evolution, current indications and outcomes of cementless total knee arthroplasty.J Clin Med. 2022; 11Crossref Scopus (2) Google Scholar,22Turkyilmaz I. Aksoy U. McGlumphy E.A. Two alternative surgical techniques for enhancing primary implant stability in the posterior maxilla: a clinical study including bone density, insertion torque, and resonance frequency analysis data.Clin Implant Dent Relat Res. 2008; 10: 231-237Crossref PubMed Scopus (131) Google Scholar Current FDA regulations will require a substantial approval process for any uncemented fixation option and will benefit from a concerted and collaborative effort by hand surgeons, engineers, and the FDA.
No takes yet. Share an insight, caveat, or question.
Bhogal et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: